Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have spe…
Insiders
Transactions
| Reported Owner(s) | Position Now | Transaction Date | Type | Position Change | Extra | ||
|---|---|---|---|---|---|---|---|
|
$25,813
d
cs
10% Holder
|
11/15/24 |
S
|
15 x $478.56 = $7,178.40 |
Footnotes
#1 Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1, which was entered into on 8/8/2024.
|
|||
|
$44,137
d
cs
10% Holder
|
11/11/24 |
S
|
3,000 x $518.27 = $1,554,810.00 |
Footnotes
#1 Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1, which was entered into on 08/08/2024.
|
|||
|
$75,772
d
cs
10% Holder
|
11/08/24 |
S
|
15,198 x $515.00 = $7,826,970.00 |
Footnotes
#1 Transaction made pursuant to Dr. Kewalramani's company approved trading plan under Rule 10b5-1, which was entered into on 02/07/2024.
|
|||
|
$16,651
d
cs
10% Holder
|
10/02/24 |
S
|
999 x $461.66 = $461,198.34 |
Footnotes
#1 Transaction made pursuant to Mr. Biller's company approved trading plan under Rule 10b5-1, which was entered into on 02/13/2024.
|
|||
|
$17,650
d
cs
10% Holder
|
10/01/24 |
F
|
630 x $466.84 = $294,109.20 |
Footnotes
#1 Transaction made pursuant to Mr. Biller's company approved trading plan under Rule 10b5-1, which was entered into on 02/13/2024.
|
|||
Get PRO Today
With PRO you will unlock 140 more insider transactions for Vertex Pharmaceuticals Incorporated
Individuals
We summarize earnings call passages, compensations, insider transactions and other information for each individual to get the bigger picture:
- Altshuler David EVP, Chief Scientific Officer
- Ambrose Kristen SVP & Chief Accounting Officer
- Arbuckle Stuart A Director
- Atkinson Edward Morrow Iii EVP, Chief Technical Ops. Off.
- Bhatia Sangeeta N. Director
- Biller Jonathan EVP and Chief Legal Officer
- Bozic Carmen EVP and CMO
- Carney Lloyd Director
- Garber Alan M Director
- Kearney Terrence C Director
- Kewalramani Reshma CEO & President
- Lagarde Michel Executive Vice President & COO
- Leiden Jeffrey M Executive Chairman
- Mckenzie Diana Director
- Sachdev Amit EVP Chief Patient & Ext Af Off
- Sachs Bruce I Director
- Schneider Jennifer Director
- Tatsis Ourania EVP, Chief Reg. & Quality Off.
- Thornberry Nancy Director
- Upadhyay Suketu Director
- Wagner Charles F Jr Director
Individuals
We summarize earnings call passages, compensations, insider transactions and other information for each individual to get the bigger picture:
- Altshuler David EVP, Chief Scientific Officer
- Ambrose Kristen SVP & Chief Accounting Officer
- Arbuckle Stuart A Director
- Atkinson Edward Morrow Iii EVP, Chief Technical Ops. Off.
- Bhatia Sangeeta N. Director
- Biller Jonathan EVP and Chief Legal Officer
- Bozic Carmen EVP and CMO
- Carney Lloyd Director
- Garber Alan M Director
- Kearney Terrence C Director
- Kewalramani Reshma CEO & President
- Lagarde Michel Executive Vice President & COO
- Leiden Jeffrey M Executive Chairman
- Mckenzie Diana Director
- Sachdev Amit EVP Chief Patient & Ext Af Off
- Sachs Bruce I Director
- Schneider Jennifer Director
- Tatsis Ourania EVP, Chief Reg. & Quality Off.
- Thornberry Nancy Director
- Upadhyay Suketu Director
- Wagner Charles F Jr Director